source
- FDA Requests Public Feedback on Designing Early-Phase Trials for Psychedelic Drug IbogaineThe U.S. Food and Drug Administration announced it is seeking comments from the public on how to structure early-phase clinical studies of ibogaine, a plant-derived psychoactive compound. The agen…
- Genentech parts ways with global AI head Richard BonneauGenentech, the Roche biotech unit, announced that its global head of artificial intelligence for drug discovery, computational biologist Richard Bonneau, has left the company effective immediately.…